Buscar

Filtros actuales:



Comenzar nueva busqueda
Añadir filtros:

Usa los filtros para afinar la busqueda.


Resultados 1-9 de 9.
  • Anterior
  • 1
  • Siguiente
Resultados por ítem:
Vista previaFecha de publicaciónTítuloAutor(es)Acceso
Influence of substituents of Perylenebisimides on the surface energy and.pdf.jpg2022Influence of substituents of Perylenebisimides on the surface energy and wettability: A systematic structure–property relationship analysis
Pérez-Ojeda, M.Eugenia; Zink Lorre, Nathalie; Pla, Sara; Sastre-Santos, Ángela; Fernández Lázaro, Fernando; Hirsch, Andreas
Sex Differences in Oxycodone Naloxone vs. Tapentadol in Chronic Non-Cancer Pain. An Observational Real-World Study.pdf.jpg2-oct-2022Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López Gil, Vicente; López Gil, Santiago; Ballester, Pura; Mira-Lorente, Laura; Agulló, Laura; Peiró, Ana
Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting. An observational study.pdf.jpg20-mar-2022Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study
Barrachina, Jordi; Margarit, César; Andreu, Blanca; Zandonai, Thomas; Ballester, Pura; Muriel, Javier; Cutillas, Esperanza; Peiró, Ana
Benzodiazepines in sport, an underestimated problem. Recommendations for sports medicine physicians’ practice.pdf.jpg21-dic-2022Benzodiazepines in sport, an underestimated problem: Recommendations for sports medicine physicians’ practice
Zandonai, Thomas; Peiró, Ana; FUSINA, FRANCESCA; Lugoboni, Fabio; Zamboni, Lorenzo
Tramadol and Cycling Is It the End of a “Painful” Relationship. An Insight From 60,802 Doping-Control Samples From 2012 to 2020.pdf.jpg5-dic-2022Tramadol and Cycling: Is It the End of a “Painful” Relationship?. An Insight From 60,802 Doping-Control Samples From 2012 to 2020
Zandonai, Thomas; Peiró, Ana; Covelli, Caterina; de la Torre, Xavier; Botré, Francesco
Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpgjun-2022Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana
Non-pharmacological therapy in chronic musculoskeletal pain.pdf.jpgsep-2022Non-pharmacological therapy in chronic musculoskeletal pain
Inda, María del Mar; Margarit, César; Vara, Amaya; Cutillas, Esperanza; Mateu, Marga; Martínez, Evan; Coves, Miriam; Rodríguez, Jorge; Ballester, Pura; Barrachina, Jordi; Morales, Domingo; Peiró, Ana
CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpgabr-2022CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesiaBallester, Pura; Muriel, Javier; Peiró, Ana
Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg18-nov-2022Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana